Gilead Sciences (GILD) Misses Q3 EPS by 11c; Reiterates Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
UPDATE: BMO Capital Maintains Gilead Sciences (GILD) at Market Perform (Correction)
November 2, 2016 6:56 AM EDT(Updated - November 2, 2016 7:17 AM EDT)
(Gilead was not upgraded to Outperform, remains Market Perform at BMO.)
BMO Capital maintained its Market Perform rating on Gilead Sciences (NASDAQ: GILD) with a price target of $84 (prior $98). Comments follow Q3 results.... More
Gilead Sciences (GILD) Declares $0.47 Quarterly Dividend; 2.5% Yield
November 1, 2016 4:04 PM EDTGilead Sciences (NASDAQ: GILD) declared a quarterly dividend of $0.47 per share, or $1.88 annualized.
The dividend will be payable on December 29, 2016, to stockholders of record on December 15, 2016, with an ex-dividend date of December 13, 2016.
The annual yield on the dividend is 2.5... More
